The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Poole Jonathan since 2016.
The trader's CIK number is 1604689.
At the time of the last reporting, Poole Jonathan was the Chief Financial Officer of Genocea Biosciences, Inc.. (stock ticker symbol GNCA).
Also see all insider trading activities at Genocea Biosciences, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2017 | GNCA | 0 | $0 | 51,213 | $310,446 | 45,000 | $139,050 |
| 2016 | GNCA | 11,000 | $38,900 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-07-24 | GNCA | Sale | 45,000 | 6.00 | 270,000 |
| 2017-07-24 | GNCA | Option Ex | 45,000 | 3.09 | 139,050 |
| 2017-05-08 | GNCA | Sale | 6,213 | 6.51 | 40,446 |
| 2016-11-07 | GNCA | Buy | 7,000 | 3.34 | 23,380 |
| 2016-05-09 | GNCA | Buy | 4,000 | 3.88 | 15,520 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Poole Jonathan (Chief Financial Officer of Genocea Biosciences, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.